• Tue news: Pfizer explores sale of hospital drugs unit. FDA declines full approval of Ocaliva. AZ better than expected Q3 results. Pfizer, Lilly telehealth platforms draw scrutiny. 23andMe cutting lays off 40%. See more on our front page

Notes from the JPM19 Vortex: Price Apocalypse, Celgene Fallout & More

cafead

Administrator
Staff member
  • cafead   Jan 11, 2019 at 10:12: AM
via Until then, the tone for the year has been set. The issues have been defined. The receptions have been cocktailed. And Xconomy was there, conducting dozens of interviews that will play out in stories across the year. For now, we present what’s top of mind, a bit off the cuff but no less serious for it, what older generations of journalists liked to call a reporter’s notebook.

article source